Would we expect new regulations evolution for "PFAS" similar to what the industry had for Nitrosamines since 2018?

Hi Everyone

I came across “PFAS” contaminants and seams that there is an evolving regulations that might rise in pharmaceutical industry, this could be similar to what we got in Nitrosamine.

Am I exagerating here?

1 Like

Thanks for bringing this.

PFAS are there is food chain from decades similar to nitrosamines.

The attempts from regulatory looks, they wanted to cut down the scale.

But coming to pharmaceuticals- Definitely a risk-benefit analysis would be considered and call will be made.

Most prominently for the fluorinated pharmaceuticals, their scale of usage might not be a real threat to humans and environment- (My personal opinion!)

1 Like